Ligand validation:4UC1

PP9: PROTOPORPHYRIN IX

PP9 is a Ligand Of Interest in 4UC1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UC1_PP9_A_207	1%	5%	0.465	0.683	2.61	2.62	11	10	26	0	100%	0.57
5DUO_PP9_A_208	1%	11%	0.506	0.596	1.83	2.37	4	8	19	0	100%	0.52
1Z53_PP9_A_296	99%	33%	0.051	0.98	1.34	1.31	4	4	0	0	100%	1
6G71_PP9_A_501	86%	40%	0.083	0.952	1.06	1.26	2	2	1	0	100%	1
5E9Z_PP9_A_502	86%	56%	0.105	0.974	0.55	1.15	-	2	0	0	100%	1
2HRE_PP9_C_605	58%	15%	0.157	0.935	1.8	2.01	8	4	5	0	100%	1
2QD1_PP9_B_702	48%	10%	0.153	0.895	1.82	2.53	8	8	10	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.